Optimal Timing of Percutaneous Coronary Intervention for Non-ST Elevated Myocardial Infarction with Congestive Heart Failure

[Speaker] 임용환
Yongwhan Lim¹, Youngkeun Ahn¹,  Min Chul Kim¹, Myung Ho Jeong¹, Ik Jun Choi², Eun Ho Choo3, Sungmin Lim4, Byung-Hee Hwang4, Mahn-Won Park5, Chan Joon Kim4, Jong-Min Lee4 , Chul Soo Park6, Hee Yeol Kim7, Ki-Dong Yoo8 and Kiyuk Chang3  
¹Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital, Gwangju, South Korea ²Division of Cardiology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ³Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ⁴Division of Cardiology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ⁵Division of Cardiology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ⁶Division of Cardiology, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ⁷Division of Cardiology, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea ⁸Division of Cardiology, Department of Internal Medicine, St Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Prognostic Implications of Pulmonary Artery Systolic Pressure change in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention 

[Speaker] 조은영
Eun Young Cho, RN, Myung Ho Jeong, MD
The Heart Center of Chonnam National University Hospital, Gwangju, Korea

Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

[Speaker] 이승헌
Seung Hun Lee, MD, PhD,¹ David Hong, MD,² Ki Hong Choi, MD, PhD,² Joo Myung Lee, MD, MPH, PhD,² Taek Kyu Park, MD, PhD,² Jeong Hoon Yang, MD, PhD,² Joo-Yong Hahn, MD, PhD,² Young Joon Hong, MD, PhD,¹ Ju Han Kim, MD, PhD,¹ Byeong-Keuk Kim, MD, PhD,³ Hyung Joon Joo, MD, PhD,⁴ Kiyuk Chang, MD, PhD,⁵ Yongwhi Park, MD, PhD,⁶ Sung Gyun Ahn, MD, PhD,⁷ Jung-Won Suh, MD, PhD,⁸ Sang Yup Lee, MD, PhD,⁹ Jung Rae Cho, MD, PhD,¹⁰ Ae-Young Her, MD, PhD,¹¹ Young-Hoon Jeong, MD, PhD,⁹ Hyo-Soo Kim, MD, PhD,¹² Moo Hyun Kim, MD, PhD,¹³ Do-Sun Lim, MD, PhD,⁴ Eun-Seok Shin, MD, PhD,¹⁴ Youngkeun Ahn, MD, PhD,¹ Seung-Hyuck Choi, MD, PhD,² Hyeon-Cheol Gwon, MD, PhD,² Myung Ho Jeong, MD, PhD,¹ Young Bin Song, MD, PhD,²; On Behalf of PTRG-DES Registry Investigators
¹Chonnam National University Hospital, Gwangju; ²Samsung Medical Center, Seoul; ³Severance Cardiovascular Hospital, Seoul; ⁴Korea University Anam Hospital, Seoul; ⁵College of Medicine, Catholic University of Korea, Seoul; ⁶Gyeongsang National University Changwon Hospital, Changwon; ⁷Yonsei University Wonju Severance Christian Hospital, Wonju; ⁸Seoul National University Bundang Hospital, Seongnam; ⁹Chung-Ang University Gwangmyeong Hospital, Gwangmyeong; ¹⁰Kangnam Sacred Heart Hospital, Seoul; ¹¹Kangwon National University School of Medicine, Chuncheon; ¹²Seoul National University Hospital, Seoul; ¹³Dong-A University Hospital, Busan; ¹⁴Ulsan University Hospital, Ulsan, South Korea.

Differences in Clinical and Angiographic Characteristics following Intracoronary Ergnovine and Acetylcholine Provocation Test for Coronary Artery Spasm 

[Speaker] 나승운
Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Jae Kyeong Byun, Jinah Cha, Byambasuren Battumur, Sujin Hyun, Soohyung Park, Dong Oh Kang, Eun Jin Park, Ji Bak Kim, Jin Oh Na, Cheol Ung Choi, Eung Ju Kim, Chang Gyu Park
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea